Resiniferatoxin |
| Catalog No.GC12783 |
Resiniferatoxin is a selective TRPV1 receptor agonist that activates TRPV1 in an irreversible manner.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 57444-62-9
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Resiniferatoxin (RTX), an ultrapotent capsaicin analog, is a vanilloid agonist that binds to the transient receptor potential channel, vanilloid subfamily member 1 (TRPV1).Resiniferatoxin activates TRPV1 in an irreversible manner. It also can bind and activate members of the PKC family[1-4].
Resiniferatoxin(0.1-10μM; 24 hours) can induce G0/G1 arrest in non-transformed intestinal epithelial cells[4].
Resiniferatoxin (250ng,50µL; s.c) blocks inflammatory heat hyperalgesia when applied directly to the sciatic nerve in a time and dose dependent fashion[5]. Resiniferatoxin treatment increased serum levels of IL-4, IL-10 and IL-13, and it decreases intestinal eosinophilia, however, favours the mastocytosis, promoting T spiralis intestinal expulsion[6]. Cutaneous injection of Resiniferatoxin(100 µL of RTX 0.002% (2 µg); s.c in the plantar skin) completely alleviates and prevents nerve-injury-induced neuropathic pain in rat[7].
References:
[1]. Brown DC. Resiniferatoxin: The Evolution of the "Molecular Scalpel" for Chronic Pain Relief. Pharmaceuticals (Basel). 2016 Aug 11;9(3):47. doi: 10.3390/ph9030047. PMID: 27529257; PMCID: PMC5039500.
[2]. Montell C, Birnbaumer L, et,al. A unified nomenclature for the superfamily of TRP cation channels. Mol Cell. 2002 Feb;9(2):229-31. doi: 10.1016/s1097-2765(02)00448-3. PMID: 11864597.
[3]. Gunthorpe MJ, Benham CD, et,al. The diversity in the vanilloid (TRPV) receptor family of ion channels. Trends Pharmacol Sci 2002, 23:183–191.
[4]. Frey MR, Clark JA, et,al. Cell cycle- and protein kinase C-specific effects of resiniferatoxin and resiniferonol 9,13,14-ortho-phenylacetate in intestinal epithelial cells. Biochem Pharmacol. 2004 May 15;67(10):1873-86. doi: 10.1016/j.bcp.2004.02.006. PMID: 15130764.
[5]. Neubert JK, Mannes AJ, et,al. Perineural resiniferatoxin selectively inhibits inflammatory hyperalgesia. Mol Pain. 2008 Jan 16;4:3. doi: 10.1186/1744-8069-4-3. PMID: 18199335; PMCID: PMC2242785.
[6]. Muñoz-Carrillo JL, Gutiérrez-Coronado O, et,al. Resiniferatoxin promotes adult worm expulsion in Trichinella spiralis-infected rats by Th2 immune response modulation. Parasite Immunol. 2021 Aug;43(8):e12840. doi: 10.1111/pim.12840. Epub 2021 May 10. PMID: 33914935.
[7]. Javed H, Johnson AM, et,al. Cutaneous Injection of Resiniferatoxin Completely Alleviates and Prevents Nerve-Injury-Induced Neuropathic Pain. Cells. 2022 Dec 14;11(24):4049. doi: 10.3390/cells11244049. PMID: 36552812; PMCID: PMC9776507.
Average Rating: 5 (Based on Reviews and 15 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *